je.st
news
Tag: vaccine
Experimental Ebola vaccine could stop virus in West Africa
2015-08-05 08:05:07| Biotech - Topix.net
An experimental Ebola vaccine tested on thousands of people in Guinea seems to work and might help shut down the waning epidemic in West Africa, according to interim results from a study published Friday. There is currently no licensed treatment or vaccine for Ebola, which has so far killed more than 11,000 people in West Africa since the world's biggest outbreak began in the forest region of Guinea last year.
Tags: west
stop
africa
experimental
Experimental Ebola vaccine could stop virus in West Africa
2015-08-01 22:58:45| Biotech - Topix.net
An experimental Ebola vaccine tested on thousands of people in Guinea seems to work and might help shut down the waning epidemic in West Africa, according to interim results from a study published Friday. There is currently no licensed treatment or vaccine for Ebola, which has so far killed more than 11,000 people in West Africa since the world's biggest outbreak began in the forest region of Guinea last year.
Tags: west
stop
africa
experimental
Ebola vaccine results 'hugely important' in tackling epidemic
2015-07-31 18:05:13| Biotech - Topix.net
An end to the Ebola epidemic in West Africa may be in sight after results from a fast-tracked vaccine trial were described as "hugely important" and "very exciting" by experts. The experimental vaccine VSV-ZEBOV was found to be 100% effective six days after it was administered to 7,651 people living in Guinea, where the virus has already claimed more than 2,500 lives.
Tags: results
important
vaccine
epidemic
In Interim Results from Phase 3 Study, Mercks Investigational Ebola Vaccine Efficacious; Study is Continuing
2015-07-31 14:10:00| Merck.com - Research & Development News
Dateline City: KENILWORTH, N.J. Global Collaboration Enabled Vaccine to Move from First-in-Human Studies to Initial Phase 3 Results Within One Year KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (known as MSD outside the US and Canada) said today that its investigational Ebola vaccine candidate, rVSV-ZEBOV, was found to have 100 percent efficacy in an analysis of interim data from a Phase 3 ring vaccination trial in Guinea. Preliminary conclusions from this study, which is continuing, were published on-line today in The Lancet. Language: English Contact: MerckMedia Contacts:Pam Eisele, 267-305-3558orInvestor Contacts:Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Pfizer's revenue, Profit Beat As Vaccine Sales Rise
2015-07-29 09:08:28| Biotech - Topix.net
Pfizer Inc reported better-than-expected quarterly profit and revenue, helped by strong demand for its pneumonia vaccine Prevnar 13 and sales of its breast cancer drug, Ibrance. The company, which also raised its full-year adjusted earnings forecast, said revenue from its global vaccines unit rose 44 percent to $1.58 billion.
Sites : [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] next »